Clinical Trial Update: Observational Study on Safety of Self-titration of Once Daily Levemir®

View source ↗

Summary

An observational study assessing the safety of self-titration of once-daily insulin detemir (Levemir) in patients with diabetes. The study has completed and rep…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Levemir (insulin detemir)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Status: COMPLETED